These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35967067)

  • 1. Toward the Development of GE11-Based Radioligands for Imaging of Epidermal Growth Factor Receptor-Positive Tumors.
    Judmann B; Braun D; Schirrmacher R; Wängler B; Fricker G; Wängler C
    ACS Omega; 2022 Aug; 7(31):27690-27702. PubMed ID: 35967067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11.
    Judmann B; Wängler B; Schirrmacher R; Fricker G; Wängler C
    Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, Radiolabeling, and
    Braun D; Judmann B; Cheng X; Wängler B; Schirrmacher R; Fricker G; Wängler C
    ACS Omega; 2023 Jan; 8(2):2793-2807. PubMed ID: 36687076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring pitfalls of
    Striese F; Sihver W; Gao F; Bergmann R; Walther M; Pietzsch J; Steinbach J; Pietzsch HJ
    Amino Acids; 2018 Oct; 50(10):1415-1431. PubMed ID: 30039310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of [
    Li X; Hu K; Liu W; Wei Y; Sha R; Long Y; Han Y; Sun P; Wu H; Li G; Tang G; Huang S
    Nucl Med Biol; 2020; 90-91():84-92. PubMed ID: 33189948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of (68)Ga-labeled NOTA-RGD-GE11 heterodimeric peptide for dual integrin and epidermal growth factor receptor-targeted tumor imaging.
    Yu HM; Chen JH; Lin KL; Lin WJ
    J Labelled Comp Radiopharm; 2015 Jun; 58(7):299-303. PubMed ID: 25997858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges for the application of EGFR-targeting peptide GE11 in tumor diagnosis and treatment.
    Hailing T; Yonghong P; Yufeng Z; Haitao T
    J Control Release; 2022 Sep; 349():592-605. PubMed ID: 35872181
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Chen CJ; Chan CH; Lin KL; Chen JH; Tseng CH; Wang PY; Chien CY; Yu HM; Lin WJ
    Nucl Med Biol; 2019; 68-69():22-30. PubMed ID: 30578136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of [64Cu]Cu-NOTA-Bn-GE11 for PET imaging of EGFR-rich tumors.
    Dejesus OT
    Curr Radiopharm; 2012 Jan; 5(1):15-8. PubMed ID: 21864245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Analysis of
    Paiva I; Mattingly S; Wuest M; Leier S; Vakili MR; Weinfeld M; Lavasanifar A; Wuest F
    Mol Pharm; 2020 May; 17(5):1470-1481. PubMed ID: 32233491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based peptide ligand design for improved epidermal growth factor receptor targeted gene delivery.
    Decker S; Taschauer A; Geppl E; Pirhofer V; Schauer M; Pöschl S; Kopp F; Richter L; Ecker GF; Sami H; Ogris M
    Eur J Pharm Biopharm; 2022 Jul; 176():211-221. PubMed ID: 35584718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of smart GE11-PLGA/PEG-PLGA blend nanoparticulate platforms for parenteral administration of hydrophilic macromolecular drugs: synthesis, preparation and in vitro/ex vivo characterization.
    Colzani B; Speranza G; Dorati R; Conti B; Modena T; Bruni G; Zagato E; Vermeulen L; Dakwar GR; Braeckmans K; Genta I
    Int J Pharm; 2016 Sep; 511(2):1112-23. PubMed ID: 27511710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PolyIC GE11 polyplex inhibits EGFR-overexpressing tumors.
    Abourbeh G; Shir A; Mishani E; Ogris M; Rödl W; Wagner E; Levitzki A
    IUBMB Life; 2012 Apr; 64(4):324-30. PubMed ID: 22362419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, In Vitro and In Vivo Evaluation of Heterobivalent SiFA
    Cheng X; Hübner R; von Kiedrowski V; Fricker G; Schirrmacher R; Wängler C; Wängler B
    Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34200477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of a novel
    Jiao H; Zhao X; Han J; Zhang J; Wang J
    Int J Radiat Biol; 2020 Nov; 96(11):1443-1451. PubMed ID: 32809887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of ligand-EGFR interactions: a platform for screening targeting molecules.
    Kuo WT; Lin WC; Chang KC; Huang JY; Yen KC; Young IC; Sun YJ; Lin FH
    PLoS One; 2015; 10(2):e0116610. PubMed ID: 25723471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced tumor-targeted gene delivery by bioreducible polyethylenimine tethering EGFR divalent ligands.
    Lee D; Lee YM; Kim J; Lee MK; Kim WJ
    Biomater Sci; 2015 Jul; 3(7):1096-104. PubMed ID: 26221943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
    Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
    Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo.
    Fang Y; Yang W; Cheng L; Meng F; Zhang J; Zhong Z
    Acta Biomater; 2017 Dec; 64():323-333. PubMed ID: 29030307
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.